Emodialisi

L'emodialisi è una terapia fisica sostitutiva della funzionalità renale somministrata a soggetti nei quali essa è criticamente ridotta (uremia), condizione che rappresenta lo stadio più grave dell'insufficienza renale.
Nell'emodialisi le prime due funzioni vengono svolte sottoponendo il sangue del paziente (da cui "emo") al principio fisico della dialisi. Esso viene fatto scorrere in un filtro in cui entra in contatto con una membrana semipermeabile attraverso cui passano solo (o almeno in maggior quantità) le sostanze tossiche che si desidera rimuovere. Il filtro consente, oltre alla rimozione di sostanze, anche il reintegro di radicali alcalini, quindi il riequilibrio acido-base.
L'ultima funzione in elenco riguarda la necessità di rimuovere i liquidi assunti attraverso l'alimentazione e non eliminati con la diuresi, che può essere estremamente ridotta o assente (anuria) nei soggetti nefropatici in fase terminale. Il metodo utilizzato è la ultrafiltrazione. (fonte: Wikipedia)
Comunicati Stampa

Global and Chinese Hemodialysis Concentrates Industry Report 2014

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) (PR Newswire - 24/10/2014) Leggi

Quanta Appoints New Chief Financial Officer

Willem has almost twenty years of investment banking, executive management and private equity experience. Amongst his achievements, Willem was pivotal in the $1.6billion turnaround and public listing of FLAG Telecom and was co-founder and CFO of Arqaam Capital, one of the largest boutique investment banks based in Dubai. Prior to joining Quanta, he was Managing Director of a private investment office, Mercantile Group.  Additionally, he has also worked at the telecommunications firm Ameritech (SBC), as well the investment banks Deutsche Bank and Panmure Gordon. More recently, he led the acquisition and the subsequent merger of the real-estate agency Humberts with Chesterton. And further, as Deputy Chairman of the enlarged group Chesterton Humberts, Willem oversaw its growth into one of the largest real-estate agencies in the UK and supported its international expansion. (PR Newswire - 07/08/2014) Leggi

Major Step Towards Portable Artificial Kidney

Today three international innovators join forces to develop and deliver to patients the world's first portable artificial kidney. Debiotech of Switzerland, AWAK of Singapore and Neokidney Development, an initiative of the Dutch Kidney Foundation, have signed a joint venture agreement to complete a functional model in 2015. Clinical trials are planned for 2017. The portable artificial kidney will enable the frequent and longer home haemodialysis that significantly improves and extends patients' lives.  (PR Newswire - 23/05/2014) Leggi

Dialysis Market by Hemodialysis, Peritoneal Dialysis & End Users - Global Forecast to 2018

The global market has been segmented into two broad segments, namely, hemodialysis (HD) and peritoneal dialysis (PD). The hemodialysis segment is further categorized into HD products and HD services. The peritoneal dialysis segment is categorized into PD products and PD services. Furthermore, this report describes the HD and PD markets based on category. In this segment, the hemodialysis market includes center use hemodialysis and home hemodialysis. The peritoneal dialysis market is categorized into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent peritoneal dialysis (IPD), and PD Plus therapy. The CCPD segment holds the largest share of the peritoneal dialysis market in 2013 and is poised to grow at a CAGR of 8.2% in the forecast period. Based on the end users, the global market is segmented into in-center dialysis and home dialysis. The global market is valued at $61.60 billion in 2013 and is expected to reach $83.20... (PR Newswire - 16/04/2014) Leggi
1 2 3
Altri nomi: Haemodialysis